Metrics

Published Proposals

Access to clinical trial data provides opportunities to conduct further research that can help advance medical science or improve patient care. This helps ensure the data provided by research participants are used to maximum effect in the creation of knowledge and understanding.

Proposal number Sponsor/Funder Title Lead researcher  
631 GSK Predictors of BPH Progression Dr. Stephen Freedland, MD Further Details
647 GSK Assessing and Reporting Heterogeneity of Treatment Effect in Randomized Clinical Trials David M. Kent, MD, MSc Further Details
651 GSK Descriptive evaluation of SAE reporting rates in vaccine clinical trials among Latin American children. Thomas Verstraeten Further Details
669 GSK A multi-center, double-blind, placebo controlled study of paroxetine and imipramine in adolescents with unipolar major depression - efficacy and adverse outcomes. Jon Jureidini Further Details
674 GSK Antiepileptic drug monotherapy for epilepsy: an overview of systematic reviews and network meta-analysis Antony Marson Further Details
911 GSK Outcome Measures in Systemic Lupus Erythematosus: Constructing a Meaningful Response Index from Existing Clinical Trial Data Lindsy Forbess, MD, MSc Further Details
945 ViiV THE CD4/CD8 RATIO AS A PREDICTOR OF NON-AIDS EVENTS DURING ANTIRRETROVIRAL THERAPY: CONFIRMATION OF ITS PREDICTIVE VALUE AND IMPACT OF MARAVIROC IN TREATMENT-EXPERIENCED PATIENTS Santiago Moreno Further Details
946 GSK, Roche Assessing models for changes in tumour size over time and how they relate to survival times. Raluca Eftimie Further Details
977 GSK The implication of central adjudication of COPD exacerbations by experts for treatment effect estimates and sample size calculation Milo Puhan Further Details
1000 GSK Review of fever and febrile convulsion rates in children after trivalent influenza vaccine. Dr Jean Li-Kim-Moy, MBBS, FRACP Further Details
First 1 2 3 4 Last